Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: Effect of L-arginine and spironolactone

Acta Physiologica

Volumn 194, Issue 1, 2008, Pages 45-55

  Paulis, L ^a,b   Matuskova, J ^a   Adamcova, M ^c   Pelouch, V ^c   Simko, J ^a   Krajcirovicova, K ^a   Potacova, A ^c   Hulin, I ^a   Janega, P ^a,b   Pechanova, O ^b   Simko, F ^a  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Fibrosis; Hypertension; Hypertrophy; L arginine; L NAME; Regression

Indexed keywords

ALKADIENE; ARGININE; ARGININE METHYL ESTER; HYDROXYPROLINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLACEBO; SPIRONOLACTONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERIAL WALL THICKENING; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; ENZYME ACTIVITY; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HYPERTENSION; MALE; MORPHOMETRICS; NONHUMAN; ORGAN WEIGHT; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RAT; REMISSION; SYSTOLIC BLOOD PRESSURE; THICKNESS;

ANIMALS; AORTA; ARGININE; FIBROSIS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MODELS, ANIMAL; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR; RECEPTORS, ALDOSTERONE; SPIRONOLACTONE;

EID: 48749087838     PISSN: 17481708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2008.01862.x     Document Type: Article

References (42)

1. Babal, P., Pechanova, O., Bernatova, I. Stvrtina, S. 1997. Chronic inhibition of NO synthesis produces myocardial fibrosis and arterial media hyperplasia. Histol Histopathol 12, 623 629.
2. Bernatova, I., Pechanova, O. Simko, F. 1999. Effect of captopril in l-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney. Exp Physiol 84, 1095 1105.
3. Bernatova, I., Pechanova, O., Pelouch, V. Simko, F. 2000. Regression of chronic l-NAME treatment-induced left ventricular hypertrophy: effect of captopril. J Mol Cell Cardiol 32, 177 185.
4. Bernatova, I., Pechanova, O., Babal, P., Kysela, S., Stvrtina, S. Andriantsitohaina, R. 2002. Wine polyphenols improve cardiovascular remodeling and vascular function in NO-deficient hypertension. Am J Physiol Heart Circ Physiol 282, 942 948.
5. Bezerra, D.G. Mandarim-de-Lacerda, C.A. 2005. Beneficial effect of simvastatin and pravastatin treatment on adverse cardiac remodelling and glomeruli loss in spontaneously hypertensive rats. Clin Sci (Lond) 108, 349 355.
6. Bredt, D.S. Snyder, S.H. 1990. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87, 682 685.
7. Brilla, C.G., Pick, R., Tan, L.B., Janicki, J.S. Weber, K.T. 1990. Remodeling of the rat right and left ventricles in experimental hypertension. Circulation Res 67, 1355 1364.
8. Chen, P.Y. Sanders, P.W. 1991. l-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest 88, 1559 1567.
9. Diamond, J.A. Phillips, R.A. 2005. Hypertensive heart disease. Hypertens Res 28, 191 202.
10. Dolber, P.C. Spach, M.S. 1993. Conventional and confocal fluorescence microscopy of collagen fibers in the heart. J Histochem Cytochem 41, 465 469.
11. Kogure, K., Watson, R., Busto, R. Abe, K. 1982. Potentiation of lipid peroxides by ischemia in rat brain. Neurochem Res 7, 437 453.
12. Kristek, F. 1997. Different structure of coronary wall in two types of hypertension: NO deficiency and SHR. In : S. Moncada, L.E. Gustafsson, N.P. Wiklund E.A. Higgs (eds) The Biology of Nitric Oxide, part 7, pp. 69. Portland Press, London.
13. Lim, D.S., Mooradian, S.J., Goldberg, C.S., Gomez, C., Crowley, D.C., Rocchini, A.P. Charpie, J.R. 2004. Effect of oral l-arginine on oxidant stress, endothelial dysfunction, and systemic arterial pressure in young cardiac transplant recipients. Am J Cardiol 94, 828 831.
14. Lowry, O.H., Rosenbrough, N.J., Farr, A.L. Randall, R.J. 1951. Protein measurement with Folin phenol reagent. J Biol Chem 193, 265 272.
15. Mandarim-de-Lacerda, C.A. Pereira, L.M. 2003. The effects of spironolactone monotherapy on blood pressure and myocardial remodeling in spontaneously hypertensive rats: a stereological study. J Biomed Sci 10, 50 57.
16. Mandarim-de-Lacerda, C.A. Pereira, L.M. 2004. Effect of telmisartan on preexistent cardiac and renal lesions in spontaneously hypertensive mature rats. Histol Histopathol 19, 727 733.
17. Matsuoka, H., Nakata, M., Kohno, K., Koga, Y., Nomura, G., Toshima, H. Imaizumi, T. 1996. Chronic l-arginine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats. Hypertension 27, 14 18.
18. Nakaki, T., Hishikawa, K., Suzuki, H., Saruta, T. Kato, R. 1990. l-arginine-induced hypotension. Lancet 336, 696.
19. Nakano, S., Kobayashi, N., Yoshida, K., Ohno, T. Matsuoka, H. 2005. Cardioprotective mechanisms of spironolactone associated with the angiotensin-converting enzyme/epidermal growth factor receptor/extracellular signal-regulated kinases, NAD(P)H oxidase/lectin-like oxidized low-density lipoprotein receptor-1, and Rho-kinase pathways in aldosterone/salt-induced hypertensive rats. Hypertens Res 28, 925 936.
20. Okazaki, H., Minamino, T., Tsukamoto, O., Kim, J., Okada, K., Myoishi, M., Wakeno, M., Takashima, S., Mochizuki, N. Kitakaze, M. 2006. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition. Hypertens Res 29, 277 284.
21. Patel, K.P., Li, Y.F. Hirooka, Y. 2001. Role of nitric oxide in central sympathetic outflow. Exp Biol Med 226, 814 824.
22. Paulis, L., Vazan, R., Simko, F., Pechanova, O., Styk, J., Babal, P. Janega, P. 2007. Morphological alterations and NO-synthase expression in the heart after continuous light exposure of rats. Physiol Res 56 (Suppl. 2 71 76.
23. Pechanova, O., Bernatova, I., Pelouch, V. Simko, F. 1997. Protein remodeling of the heart in NO-deficient hypertension: the effect of captopril. J Mol Cell Cardiol 29, 3365 3374.
24. Peng, H., Carretero, O.A., Vuljaj, N., Liao, T.D., Motivala, A., Peterson, E.L. Rhaleb, N.E. 2005. Angiotensin-converting enzyme inhibitors: a new mechanism of action. Circulation 112, 2436 2445.
25. Pitt, B., Zannad, F., Remme, W.J., Cody, R., Castaigne, A., Perez, A., Palensky, J. Wittes, J. RALES Study Investigators. 1999. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341, 709 717.
26. Reddy, G.K. Enwemeka, C.S. 1996. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 29, 225 229.
27. Rossi, M.A. Colombini-Netto, M. 2001. Chronic inhibition of NO synthesis per se promotes structural intimal remodeling of the rat aorta. J Hypertens 19, 1567 1579.
28. Rossi, M.A. Peres, L.C. 1992. Effect of captopril on the prevention and regression of myocardial cell hypertrophy and interstitial fibrosis in pressure overload cardiac hypertrophy. Am Heart J 124, 700 709.
29. Rossi, M.A., Ramos, S.G. Prado, C.M. 2003. Chronic inhibition of nitric oxide synthase induces hypertension and cardiomyocyte mitochondrial and myocardial collagen remodelling in the absence of hypertrophy. J Hypertens 21, 993 1001.
30. Simko, F. Simko, J. 2000. The potential role of nitric oxide in the hypertrophic growth of the left ventricle. Physiol Res 49, 37 46.
31. Simko, F., Luptak, I., Matuskova, J., Babal, P., Pechanova, O., Bernatova, I. Hulin, I. 2002. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency. Ann N Y Acad Sci 967, 454 462.
32. Simko, F., Matuskova, J., Luptak, I., Krajcirovicova, K., Kucharska, J., Gvozdjakova, A., Babal, P. Pechanova, O. 2004. Effect of simvastatin on remodeling of the left ventricle and aorta in l-NAME-induced hypertension. Life Sci 74, 1211 1224.
33. Simko, F., Luptak, I., Matuskova, J., Krajcirovicova, K., Sumbalova, Z., Kucharska, J., Gvozdjakova, A., Simko, J., Babal, P., Pechanova, O. Bernatova, I. 2005. l-arginine fails to protect against myocardial remodelling in l-NAME-induced hypertension. Eur J Clin Invest 35, 362 368.
34. Sventek, P., Li, J.S., Grove, K., Deschepper, C.F. Schiffrin, E.L. 1996. Vascular structure and expression of endothelin-1 gene in l-NAME-treated spontaneously hypertensive rats. Hypertension 27, 49 55.
35. Takano, H., Zou, Y., Hasegawa, H., Akazawa, H., Nagai, T. Komuro, I. 2003. Oxidative stress-induced signal transduction pathways in cardiac myocytes: involvement of ROS in heart diseases. Antioxid Redox Signal 5, 789 794.
36. Takemoto, M., Egashira, K., Usui, M., Numaguchi, K., Tomita, H., Tsutsui, H., Shimokawa, H., Sueishi, K. Takeshita, A. 1997. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest 99, 278 287.
37. Torok, J., Babal, P., Matuskova, J., Luptak, I., Klimes, I. Simko, F. 2002. Impaired endothelial function of thoracic aorta in hereditary hypertriglyceridemic rats. Ann N Y Acad Sci 967, 469 475.
38. Usui, M., Ichiki, T., Katoh, M., Egashira, K. Takeshita, A. 1998. Regulation of angiotensin II receptor expression by nitric oxide in rat adrenal gland. Hypertension 32, 527 533.
39. Van Aelst, L. D'Souza-Schorey, C. 1997. Rho GTPases and signaling networks. Genes Dev 11, 2295 2322.
40. Weber, K. 2001. Cardioreparation in hypertensive heart disease. Hypertension 38, 588 591.
41. Yoshida, K., Kim-Mitsuyama, S., Wake, R., Izumiya, Y., Izumi, Y., Yukimura, T., Ueda, M., Yoshiyama, M. Iwao, H. 2005. Excess aldosterone under normal salt diet induces cardiac hypertrophy and infiltration via oxidative stress. Hypertens Res 28, 447 455.
42. Zannad, F., Alla, F., Dousset, B., Perez, A. Pitt, B. RALES Investigators. 2000. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Circulation 28, 2700 2706.